CytoSorbents gets new $20M credit facility (NASDAQ:CTSO)
2024-07-02
CytoSorbents (NASDAQ:CTSO) said it has entered into a new $20 million credit facility with Avenue Capital. The proceeds are expected to provide non-dilutive working capital to support the company’s ongoing global CytoSorb franchise in critical care and cardiac surgery. The agreement has an initial term of three years, provides up toContinue Reading